Frisiosol 1,5 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis България - български - Изпълнителна агенция по лекарствата

frisiosol 1,5 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis

fresenius medical care deutschland gmbh - Глюкоза - 1,5 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis

Frisiosol 4,25 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis България - български - Изпълнителна агенция по лекарствата

frisiosol 4,25 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis

fresenius medical care deutschland gmbh - Глюкоза - 4,25 % glucose, 1,25 mmol/l calcium solution for pritoneal dialysis

Frisiosol 2,3 % glucose, 1,25 mmol/l calcuim solution for peritoneal dialysis България - български - Изпълнителна агенция по лекарствата

frisiosol 2,3 % glucose, 1,25 mmol/l calcuim solution for peritoneal dialysis

fresenius medical care deutschland gmbh - Глюкоза - 2,3 % glucose, 1,25 mmol/l calcuim solution for peritoneal dialysis

Kreon 25 000 Ph. Eur. U  gastro - resistant capsules, hard България - български - Изпълнителна агенция по лекарствата

kreon 25 000 ph. eur. u  gastro - resistant capsules, hard

mylan healthcare gmbh - multienzymes (липаза, протеазни и т.н.) - gastro - resistant capsules, hard

Kymriah Европейски съюз - български - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Други антинеопластични средства - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.